The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Loser, Karin ^a   Brzoska, Thomas ^a   Oji, Vinzenz ^a   Auriemma, Matteo ^a   Voskort, Maik ^a   Kupas, Verena ^a   Klenner, Lars ^a   Mensing, Cornelius ^b   Hauschild, Axel ^b   Beissert, Stefan ^a   Luger, Thomas A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; MELANOCORTIN 1 RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CD8+ T LYMPHOCYTE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOMA CELL; MOUSE; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; UPREGULATION;

ADOPTIVE TRANSFER; ALPHA-MSH; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DERMATITIS, CONTACT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HORMONES; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, MELANOCORTIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

MURINAE; MUS;

EID: 77957309802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008958     Document Type: Article

References (74)

1. Lipton JM, Catania A (1997) Anti-inflammatory actions of the neuroimmuno-modulator α-MSH. Immunol Today 18: 140-145.
2. Botchkarev VA, Botchkareva NV, Slominski A, Roloff B, Luger T, et al. (1999) Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann N Y Acad Sci 885: 433-439.
3. Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkötter C, et al. (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917: 232-238.
4. Luger TA, Scholzen TE, Brzoska T, Böhm M (2003) New insights into the functions of α-MSH and related peptides in the immune system. Ann N Y Acad Sci 994: 133-140.
5. Lipton JM, Zhao H, Ichiyama T, Barsh GS, Catania A (1999) Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann N Y Acad Sci 885: 173-182.
6. Luger TA, Bhardwaj RS, Grabbe S, Schwarz T (1996) Regulation of the immune response by epidermal cytokines and neurohormones. J Dermatol Sci 13: 5-10.
7. Cutuli M, Cristiani S, Lipton JM, Catania A (2000) Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol 67: 233-239.
8. Star RA, Rajora N, Huang J, Stock RC, Catania A, et al. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92: 8016-8020.
9. Catania A, Rajora N, Capsoni F, Minonzio R, Star RA, et al. (1996) The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17: 675-679.
10. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1250.
11. Schiöth HB, Muceniece R, Larsson M, Mutulis F, Szardenings M, et al. (1997) Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. J Pharmacol 319: 369-373.
12. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, et al. (2004) α-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 122: 1010-1019.
13. Chhajlani V, Wikberg JES (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309: 417-420.
14. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M (2008) α-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Rev 29: 581-602.
15. Abdel-Malek ZA, Knittel J, Kadekaro AL, Swope VB, Starner R (2008) The melanocortin 1 receptor and the UV response of human melanocytes-a shift in paradigm. Photochem Photobiol 84: 501-508.
16. Becher E, Mahnke K, Brzoska T, Kalden DH, Grabbe S, et al. (1999) Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann N Y Acad Sci 885: 188-195.
17. Adachi S, Nakano T, Vliagoftis H, Metcalfe DD (1999) Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J Immunol 163: 3363-3368.
18. Mountjoy KG (1994) The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol Cell Endocrinol 102: R7-R11.
19. Manna SK, Aggarwal BB (1998) Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 161: 2873-2880.
20. Yoon SW, Goh SH, Chun JS, Cho EW, Lee MK, et al. (2003) Alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem 278: 32914-32920.
21. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, et al. (1999) Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol 99: 211-217.
22. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, et al. (1996) α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156: 473-478.
23. Rajora N, Boccoli G, Catania A, Lipton JM (1997) α-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381-385.
24. Lipton JM, Ceriani G, Macalusco A, McCoy D, Carnes K, et al. (1994) Antiinflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation. Ann N Y Acad Sci 741: 137-148.
25. Han D, Tian Y, Zhang M, Zhou Z, Lu J (2007) Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated α-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther 14: 383-395.
26. Raap U, Brzoska T, Sohl S, Path G, Emmel J, et al. (2003) α-Melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171: 353-359.
27. Nishida T, Miyata S, Itoh Y, Mizuki N, Ohgami K, et al. (2004) Antiinflammatory effects of α-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 4: 1059-1066.
28. Wikberg JES, Muceniece R, Mandrika I, Prusis J, Post C, et al. (2000) New aspects on the melanocortins and their receptors. Pharmacol Res 42: 393-420.
29. Cavani A (2008) T cell regulation in allergy, asthma and atopic skin diseases. Chem Immunol Allergy 94: 93-100.
30. Melief CJ, Kast WM (1991) Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms. Semin Cancer Biol 2: 347-354.
31. Kameyama K, Vieira WD, Tsukamoto K, Law LW, Hearing VJ (1990) Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells. Int J Cancer 45: 1151-1158.
32. thor Straten P, Becker JC, Guldberg P, Zeuthen J (1999) In situ T cells in melanoma. Cancer Immunol Immunother 48: 386-395.
33. Rees JL (2000) The melanocortin 1 receptor (MC1R): more than just red hair. Pigment Cell Res 13: 135-140.
34. Rees JL (2003) Genetics of hair and skin color. Annu Rev Genet 37: 67-90.
35. Wong TH, Rees JL (2005) The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides 26: 1965-1971.
36. Mössner R, Anders N, König IR, Krüger U, Schmidt D, et al. (2007) Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res 298: 371-379.
37. Sturm RA (2002) Skin colour and skin cancer-MC1R, the genetic link. Melanoma Res 12: 405-416.
38. Lin J, Hocker TL, Singh M, Tsao H (2008) Genetics of melanoma predisposition. Br J Dermatol 159: 286-291.
39. Sánchez-Laorden BL, Jiménez-Cervantes C, García-Borrón JC (2007) Regulation of human melanocortin 1 receptor signaling and trafficking by Thr-308 and Ser-316 and its alteration in variant alleles associated with red hair and skin cancer. J Biol Chem 282: 3241-3251.
40. Fargnoli MC, Chimenti S, Keller G, Höfler H, Peris K (2003) Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum Mutat 21: 655.
41. Schiöth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, et al. (1999) Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260: 488-491.
42. Maaser C, Kannengiesser K, Kucharzik T (2006) Role of the melanocortin system in inflammation. Ann N Y Acad Sci 1072: 123-134.
43. Lunec J, Pieron C, Thody AJ (1992) MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res 2: 5-12.
44. Gehlsen KR, Hadley ME, Levine N, Ray CG, Hendrix MJ (1992) Effects of a melanotropic peptide on melanoma cell growth, metastasis, and invasion. Pigment Cell Res 5: 219-223.
45. Eves P, Haycock J, Layton C, Wagner M, Kemp H, et al. (2003) Antiinflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br J Cancer 89: 2004-2015.
46. Morandini R, Boeynaems JM, Hedley SJ, MacNeil S, Ghanem G (1998) Modulation of ICAM-1 expression by alpha-MSH in human melanoma cells and melanocytes. J Cell Physiol 175: 276-282.
47. Hedley SJ, Gawkrodger DJ, Weetman AP, Morandini R, Boeynaems JM, et al. (1998) Alpha-melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol 138: 536-543.
48. Kalden DH, Scholzen T, Brzoska T, Luger TA (1999) Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann N Y Acad Sci 885: 254-261.
49. Lee JH, Park H, Chung H, Choi S, Kim Y, et al. (2009) Syndecan-2 regulates the migratory potential of melanoma cells. J Biol Chem 284: 27167-27175.
50. Hedley SJ, Murray A, Sisley K, Ghanem G, Morandini R, et al. (2000) Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma Res 10: 323-330.
51. Morton DL, Eilber FR, Malmgren RA (1971) Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas. Prog Exp Tumor Res 14: 25-42.
52. Barnetson RS, Halliday GM (1997) Regression in skin tumours: a common phenomenon. Australas J Dermatol 38: S63-S65.
53. High WA, Stewart D, Wilbers CR, Cockerell CJ, Hoang MP, et al. (2005) Completely regressed primary cutaneous malignant melanoma with nodal and/ or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria. J Am Acad Dermatol 53: 89-100.
54. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T, et al. (1997) Evidence for the differential expression of the functional α-melanocyte- stimulating hormone receptor MC-1 on human monocytes. J Immunol 158: 3378-3384.
55. Cooper A, Robinson SJ, Pickard C, Jackson CL, Friedmann PS, et al. (2005) α-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 175: 4806-4813.
56. Neumann-Andersen G, Hägglund M, Nagaeva O, Frängsmyr L, Petrovska R, et al. (2005) Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol 61: 279-284.
57. Neumann-Andersen G, Nagaeva O, Mandrika I, Petrovska R, Mucheniece R, et al. (2001) MC1 receptors are constitutively expressed on leukocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126: 441-446.
58. Maaser C, Kannengiesser K, Specht C, Lügering A, Brzoska T, et al. (2006) Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55: 1415-1422.
59. Rees JL (2004) The genetics of sun sensitivity in humans. Am J Hum Genet 75: 739-751.
60. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, et al. (2004) Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptors that are associated with red hair. J Invest Dermatol 123: 917-923.
61. Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, et al. (2004) Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarker Prev 13: 808-819.
62. Makova K, Norton H (2005) Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humans. Peptides 26: 1901-1908.
63. Sturm RA, Teasdale RD, Box NF (2001) Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277: 49-62.
64. Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, et al. (2004) Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13: 447-461.
65. Scott MC, Wakamatsu K, Ito S, Kadekaro AL, Kobayashi N, et al. (2002) Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 115: 2349-2355.
66. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, et al. (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117: 294-300.
67. Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, et al. (2001) Leiden Skin Cancer Study Team. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 68: 884-894.
68. Box NF, Duffy DL, Irving RE, Russell A, Chen W, et al. (2001) Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 116: 224-229.
69. Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, et al. (2006) Epidermal RANKL controls regulatory T cell numbers. Nat Med 12: 1372-1379.
70. Loser K, Hansen W, Apelt J, Balkow S, Buer J, et al. (2005) In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 12: 1294-1304.
71. Tenaud I, Khammari A, Dreno B (2007) In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol 16: 500-506.
72. Gunzer M, Weishaupt C, Planelles L, Grabbe S (2001) Two-step negative enrichment of CD4+ and CD8+ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail. J Immunol Methods 258: 55-63.
73. Balkow S, Loser K, Krummen M, Higuchi T, Rothoeft T, et al. (2009) Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity. Exp Dermatol 18: 78-87.
74. Bellone M, Cantarella D, Castiglioni P, Crosti MC, Ronchetti A, et al. (2000) Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma. J Immunol 165: 2651-2656.